EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieKohortenstudieOpen Access · CC BY-NC 4.0

Impact of oral glucocorticoids on the effectiveness of romosozumab: the multicenter OASIS cohort study

Toshitaka Yukishima, Tomonori Kobayakawa, Yuji Hirano, Yasuhide Kanayama, Rui Niimi, Yuki Etani, Takaaki Noguchi, Taiji Noguchi, Kumiko Shimoyama, Yuichiro Maekawa, Toshiyuki Ojima, Ken Nakata und 2 weitere

Osteoporosis International · 2026

DOI: 10.1007/s00198-026-08051-0 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Osteoporosis International, 2026. Verfasst von Toshitaka Yukishima und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Internal Medicine Ⅲ, Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-Ku, Hamamatsu, Shizuoka, 431-3192, Jap…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Bone Density Conservation Agents, Glucocorticoids, Osteoporosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Grant-in-Aid for Science Research from the Japanese Osteoporosis Society, The University of Osaka.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalBone Density Conservation AgentsGlucocorticoidsOsteoporosisAgedAged, 80 and overFemaleHumansMaleMiddle AgedAdministration, OralBiomarkersBone DensityBone RemodelingHip JointLumbar VertebraeRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

Bone mineral densityBone turnover markerGlucocorticoidGlucocorticoid-induced osteoporosisRomosozumab

Substanzen

Antibodies, MonoclonalBiomarkersBone Density Conservation AgentsGlucocorticoidsromosozumab

Autor:innen und Institutionen

  • Division of Rheumatology, Internal Medicine Ⅲ, Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-Ku, Hamamatsu, Shizuoka, 431-3192, Japan.
  • Kobayakawa Orthopaedics and Rheumatologic Clinic, 1969 , Kuno, Fukuroi, Shizuoka, Japan.
  • Department of Rheumatology, Toyohashi Municipal Hospital, 50 Aza Hachiken Nishi, Aotake, Toyohashi, Aichi, 441-8570, Japan.
  • Department of Orthopedic Surgery and Rheumatology, Toyota Kosei Hospital, 500-1 Ibobara Josui, Toyota, Aichi, 470-0396, Japan.
  • Niimi Orthopaedic Clinic, 2029 , Akao, Kuwana, Mie, Japan.
  • Department of Sports Medical Biomechanics, Graduate School of Medicine Faculty of Medicine, The University of Osaka, 2-2 Yamada-Oka, Suita, Osaka, 565-0871, Japan.

Förderung

  • Grant-in-Aid for Science Research from the Japanese Osteoporosis Society
  • The University of Osaka

Zitieren

APA

Yukishima, T., Kobayakawa, T., Hirano, Y., Kanayama, Y., Niimi, R., Etani, Y., Noguchi, T., Noguchi, T., Shimoyama, K., Maekawa, Y., Ojima, T., Nakata, K., Okada, S., & Ebina, K. (2026). Impact of oral glucocorticoids on the effectiveness of romosozumab: the multicenter OASIS cohort study. Osteoporosis International. https://doi.org/10.1007/s00198-026-08051-0

Vancouver

Yukishima T, Kobayakawa T, Hirano Y, Kanayama Y, Niimi R, Etani Y, et al. Impact of oral glucocorticoids on the effectiveness of romosozumab: the multicenter OASIS cohort study. Osteoporosis International. 2026. doi:10.1007/s00198-026-08051-0

BibTeX
@article{Yukishima2026,
  author = {Yukishima, Toshitaka and Kobayakawa, Tomonori and Hirano, Yuji and Kanayama, Yasuhide and Niimi, Rui and Etani, Yuki and Noguchi, Takaaki and Noguchi, Taiji and Shimoyama, Kumiko and Maekawa, Yuichiro and Ojima, Toshiyuki and Nakata, Ken and Okada, Seiji and Ebina, Kosuke},
  title = {Impact of oral glucocorticoids on the effectiveness of romosozumab: the multicenter OASIS cohort study},
  journal = {Osteoporosis International},
  year = {2026},
  doi = {10.1007/s00198-026-08051-0}
}
Kostenlos starten →